United Airlines AFA MEC Website

Association of Flight Attendants-CWA United Master Executive Council

Changes to DOT Testing Take Effect January 1, 2018

Date: December 29, 2017
Type: AFA Article

As previously communicated in AFA E-Lines publication dated December 5, 2017. The DOT has issued a final notice that four (4) commonly prescribed medications will be added to the DOT testing program effective January 1, 2018.  

These 4 medications fall under a category of drugs known as opioids.  They include:

  • Hydrocodone (example:VicodinLortabLorcetMaxidoneNorcoZydone)
  • Hydromorphone (example:Diluadid, Exalgo, Hydromorph Contin, Palladone)
  • Oxycodone (example:Percocet, Percodan, OxyContin, Roxicodone, Endocet, Xtampza, OxylR)
  • Oxymorphone (example:Opana, Numorphan).

Opioid medications are typically prescribed for the management of pain after injury, surgery, dental procedures and diagnosis of a medical illness with painful symptoms. Please review the Important Regulatory Clarifications and the Resources provided by AFA EAP to Help You Balance Safety and Medication. 

Have more Questions? Contact Your AFA EAP Help Line at 800-424-2406.

Return to EAP Home Page